Hubert Vesselle, PhD, MD

Nuclear Medicine

Professor
PET/CT Fellowship Director
Director of Global Health

Biography

Dr. Vesselle is a UW professor of Radiology, UW Division of Nuclear Medicine. He specializes in evaluating complex cancer cases with PET/CT and SPECT/CT scanners. In addition to devoting himself to the application of these hybrid scanners to cancer and non-cancer patients, he also practices general nuclear medicine and cross-sectional imaging (CT). His research aims at applying and improving hybrid imaging to better characterize diseases and their response to treatments.

Dr. Vesselle trained as an engineer in France and then moved to the United States to earn a PhD in biomedical engineering and then his MD degree from Case Western Reserve University in Cleveland. He pursued his graduate medical education in diagnostic radiology and nuclear radiology at University Hospitals of Cleveland and the Cleveland Clinic. In 1997, he came to the UW to join the faculty of the Department of Radiology. Since 2006, he has been the director of the UW Division of Nuclear Medicine in the Department of Radiology.

He is listed in “”The Best Doctors in America”” and in “”Seattle Met Top Doctors””. He is board-certified in diagnostic radiology with special competence in nuclear radiology.

Awards and Honors

• Seattle Met Top Doctor, July 20, 2017

Recent Publications (via Semantic Scholar)

Independent Association of Metabolic Tumor Response on FDG-PET with Pulmonary Toxicity Following Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer: Inherent Radiosensitivity or Immune Response?
Evan D H Gates, D. Hippe, H. Vesselle, et al. - Published 2023 - RADIOTHERAPY AND ONCOLOGY

Utilizing Clinical Trial Data to Assess Timing of Surgical Treatment for Emphysema Patients
Maryam Alimohammadi, W. Chaovalitwongse, H. Vesselle, et al. - Published 2022 - MEDICAL DECISION MAKING

Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
H. Thomas, D. Hippe, Parisa Forouzannezhad, et al. - Published 2022 - DISCOVER ONCOLOGY

Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID‐19
S. Alam, S. Vinayak, Adeel Shah, et al. - Published 2022 - JOURNAL OF THE AMERICAN HEART ASSOCIATION : CARDIOVASCULAR AND CEREBROVASCULAR DISEASE

Assessment of cardiovascular & pulmonary pathobiology in vivo during acute COVID-19
S. Alam, S. Vinayak, A. Shah, et al. - Published 2022 - MEDRXIV

Prognostic value and peripheral immunologic correlates of early FDG PET response imaging in a phase II trial of risk-adaptive chemoradiation for unresectable non-small cell lung cancer
S. Bowen, D. Hippe, H. Thomas, et al. - Published 2021 - MEDRXIV

Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.
K. Horn, H. Thomas, H. Vesselle, et al. - Published 2021 - CLINICAL NUCLEAR MEDICINE

A Phase I Trial of First-in-Human Alpha-Emitter Astatine-211-Labeled Anti-CD45 Antibody (211At-BC8-B10) in Combination with Fludarabine and TBI As Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Refractory/Relapsed Leukemia or High-Risk Myelodysplastic Syndrome
B. Sandmaier, D. Wilbur, D. Hamlin, et al. - Published 2021

Clinical Impact of FDG PET/CT of the Lower Extremities in Patients With Merkel Cell Carcinoma With Primary Disease Site Outside of the Lower Extremities.
M. Ishiyama, F. Behnia, H. Vesselle - Published 2021 - AJR. AMERICAN JOURNAL OF ROENTGENOLOGY

Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer
K. Eaton, Perrin E. Romine, R. Martins, et al. - Published 2021 - CUREUS